Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Biopharmaceutical Market Report by Indication (Autoimmune Diseases, Oncology, Metabolic Disorders, and Others), Class (Recombinant Proteins, Monoclonal Antibodies, Purified Proteins), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A722
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
5 Global Biopharmaceutical Market
5.1 Market Performance and Forecast
5.1.1 Current Performance (2018-2023)
5.1.2 Market Forecast (2024-2032)
5.2 Impact of COVID-19
5.3 Market by Region
5.3.1 Current Performance (2018-2023)
5.3.2 Market Forecast (2024-2032)
5.4 Market by Indication
5.4.1 Autoimmune Diseases
5.4.2 Oncology
5.4.3 Metabolic Disorders
5.4.4 Others
5.5 Market by Class
5.5.1 Recombinant Proteins
5.5.1.1 Current Performance (2018-2023)
5.5.1.2 Market Forecast (2024-2032)
5.5.2 Monoclonal Antibodies
5.5.2.1 Current Performance (2018-2023)
5.5.2.2 Market Forecast (2024-2032)
5.5.3 Purified Proteins
5.5.3.1 Current Performance (2018-2023)
5.5.3.2 Market Forecast (2024-2032)
5.6 Competitive Landscape
5.6.1 Top Biopharmaceutical Players
5.6.2 Top Biopharmaceutical Drugs
5.7 Value Chain Analysis
5.8 Porter’s Five Forces Analysis
5.8.1 Overview
5.8.2 Bargaining Power of Buyers
5.8.3 Bargaining Power of Suppliers
5.8.4 Degree of Rivalry
5.8.5 Threat of New Entrants
5.8.6 Threat of Substitutes
6 North America
6.1 United States
6.1.1 Market Performance (2018-2023)
6.1.2 Market by Class
6.1.2.1 Recombinant Proteins
6.1.2.2 Monoclonal Antibodies
6.1.2.3 Purified Proteins
6.1.3 Top Players
6.1.4 Market Forecast (2024-2032)
6.2 Canada
6.2.1 Market Performance (2018-2023)
6.2.2 Market by Class
6.2.2.1 Recombinant Proteins
6.2.2.2 Monoclonal Antibodies
6.2.2.3 Purified Proteins
6.2.3 Top Players
6.2.4 Market Forecast (2024-2032)
7 Latin America
7.1 Mexico
7.1.1 Market Performance (2018-2023)
7.1.2 Market by Class
7.1.2.1 Recombinant Proteins
7.1.2.2 Monoclonal Antibodies
7.1.2.3 Purified Proteins
7.1.3 Top Players
7.1.4 Market Forecast (2024-2032)
7.2 Brazil
7.2.1 Market Performance (2018-2023)
7.2.2 Market by Class
7.2.2.1 Recombinant Proteins
7.2.2.2 Monoclonal Antibodies
7.2.2.3 Purified Proteins
7.2.3 Top Players
7.2.4 Market Forecast (2024-2032)
7.3 Argentina
7.3.1 Market Performance (2018-2023)
7.3.2 Market by Class
7.3.2.1 Recombinant Proteins
7.3.2.2 Monoclonal Antibodies
7.3.2.3 Purified Proteins
7.3.3 Top Players
7.3.4 Market Forecast (2024-2032)
8 Europe
8.1 Germany
8.1.1 Market Performance (2018-2023)
8.1.2 Market by Class
8.1.2.1 Recombinant Proteins
8.1.2.2 Monoclonal Antibodies
8.1.2.3 Purified Proteins
8.1.3 Top Players
8.1.4 Market Forecast (2024-2032)
8.2 France
8.2.1 Market Performance (2018-2023)
8.2.2 Market by Class
8.2.2.1 Recombinant Proteins
8.2.2.2 Monoclonal Antibodies
8.2.2.3 Purified Proteins
8.2.3 Top Players
8.2.4 Market Forecast (2024-2032)
8.3 Italy
8.3.1 Market Performance (2018-2023)
8.3.2 Market by Class
8.3.2.1 Recombinant Proteins
8.3.2.2 Monoclonal Antibodies
8.3.2.3 Purified Proteins
8.3.3 Top Players
8.3.4 Market Forecast (2024-2032)
8.4 Spain
8.4.1 Market Performance (2018-2023)
8.4.2 Market by Class
8.4.2.1 Recombinant Proteins
8.4.2.2 Monoclonal Antibodies
8.4.2.3 Purified Proteins
8.4.3 Top Players
8.4.4 Market Forecast (2024-2032)
8.5 United Kingdom
8.5.1 Market Performance (2018-2023)
8.5.2 Market by Class
8.5.2.1 Recombinant Proteins
8.5.2.2 Monoclonal Antibodies
8.5.2.3 Purified Proteins
8.5.3 Top Players
8.5.4 Market Forecast (2024-2032)
8.6 Russia
8.6.1 Market Performance (2018-2023)
8.6.2 Market by Class
8.6.2.1 Recombinant Proteins
8.6.2.2 Monoclonal Antibodies
8.6.2.3 Purified Proteins
8.6.3 Top Players
8.6.4 Market Forecast (2024-2032)
8.7 Turkey
8.7.1 Market Performance (2018-2023)
8.7.2 Market by Class
8.7.2.1 Recombinant Proteins
8.7.2.2 Monoclonal Antibodies
8.7.2.3 Purified Proteins
8.7.3 Top Players
8.7.4 Market Forecast (2024-2032)
9 Asia Pacific
9.1 Japan
9.1.1 Market Performance (2018-2023)
9.1.2 Market by Class
9.1.2.1 Recombinant Proteins
9.1.2.2 Monoclonal Antibodies
9.1.2.3 Purified Proteins
9.1.3 Top Players
9.1.4 Market Forecast (2024-2032)
9.2 China
9.2.1 Market Performance (2018-2023)
9.2.2 Market by Class
9.2.2.1 Recombinant Proteins
9.2.2.2 Monoclonal Antibodies
9.2.2.3 Purified Proteins
9.2.3 Top Players
9.2.4 Market Forecast (2024-2032)
9.3 Australia
9.3.1 Market Performance (2018-2023)
9.3.2 Market by Class
9.3.2.1 Recombinant Proteins
9.3.2.2 Monoclonal Antibodies
9.3.2.3 Purified Proteins
9.3.3 Top Players
9.3.4 Market Forecast (2024-2032)
9.4 South Korea
9.4.1 Market Performance (2018-2023)
9.4.1.1 Recombinant Proteins
9.4.1.2 Monoclonal Antibodies
9.4.1.3 Purified Proteins
9.4.2 Top Players
9.4.3 Market Forecast (2024-2032)
9.5 India
9.5.1 Market Performance (2018-2023)
9.5.2 Market by Class
9.5.2.1 Recombinant Proteins
9.5.2.2 Monoclonal Antibodies
9.5.2.3 Purified Proteins
9.5.3 Top Players
9.5.4 Market Forecast (2024-2032)
9.6 Indonesia
9.6.1 Market Performance (2018-2023)
9.6.2 Market by Class
9.6.2.1 Recombinant Proteins
9.6.2.2 Monoclonal Antibodies
9.6.2.3 Purified Proteins
9.6.3 Top Players
9.6.4 Market Forecast (2024-2032)
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Competitive Landscape
11.1 Market Structure
11.2 Key Players
11.3 Profiles of Key Players
11.3.1 AbbVie Inc.
11.3.2 Amgen Inc
11.3.3 Biogen Inc.
11.3.4 Eli Lilly and Company
11.3.5 F. Hoffmann-La Roche AG
11.3.6 Johnson & Johnson
11.3.7 Merck & Co. Inc.
11.3.8 Novo Nordisk A/S
11.3.9 Pfizer Inc.
11.3.10 Sanofi S.A
List of Figures
Figure 1: Global: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 2: Complexity of Biopharmaceuticals
Figure 3: Sources of Biopharmaceuticals
Figure 4: Global: Biopharmaceutical Market: Value Trends (in Billion US$), 2018-2023
Figure 5: Global: Biopharmaceutical Market Forecast: Value Trends (in Billion US$), 2024-2032
Figure 6: Global: Biopharmaceutical Market: Sales Share by Country (in %), 2023
Figure 7: Global: Biopharmaceutical Market Forecast: Sales Share by Country (in %), 2032
Figure 8: Global: Biopharmaceutical Market: Sales Share by Indication (in %), 2023
Figure 9: Global: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 10: Global: Biopharmaceutical Market Forecast: Sales by Class (in Million US$), 2024-2032
Figure 11: Global: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 12: Global: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 13: Global: Recombinant Proteins Market Forecast (in Million US$), 2024-2032
Figure 14: Global: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 15: Global: Monoclonal Antibodies Market: Sales Share by Class (in %), 2023
Figure 16: Global: Monoclonal Antibodies Market Forecast (in Million US$), 2024-2032
Figure 17: Global: Purified Proteins Market (in Million US$), 2018-2023
Figure 18: Global: Purified Proteins Market: Sales Share by Class (in %), 2023
Figure 19: Global: Purified Proteins Market Forecast (in Million US$), 2024-2032
Figure 20: Global: Biopharmaceutical Market: Sales Share of Top Biopharmaceuticals (in %)
Figure 21: Global: Biopharmaceutical Industry: Value Chain Analysis
Figure 22: Global: Biopharmaceutical Industry: Porter’s Five Forces Analysis
Figure 23: United States: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 24: United States: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 25: United States: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 26: United States: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 27: United States: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 28: United States: Monoclonal Antibodies Market: Sales Share by Class (in %), 2023
Figure 29: United States: Purified Proteins Market (in Million US$), 2018-2023
Figure 30: United States: Purified Proteins Market: Sales Share by Class (in %), 2023
Figure 31: United States: Biopharmaceutical Market: Sales Share of Top Players (in %), 2023
Figure 32: United States: Biopharmaceutical Market Forecast (in Million US$), 2024-2032
Figure 33: United States: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 34: Canada: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 35: Canada: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 36: Canada: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 37: Canada: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 38: Canada: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 39: Canada: Monoclonal Antibodies Market: Sales Share by Class (in %), 2023
Figure 40: Canada: Biopharmaceutical Market: Sales Share of Top Players (in %), 2023
Figure 41: Canada: Biopharmaceutical Market Forecast (in Million US$), 2024-2032
Figure 42: Canada: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 43: Mexico: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 44: Mexico: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 45: Mexico: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 46: Mexico: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 47: Mexico: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 48: Mexico: Monoclonal Antibodies Market: Sales Share by Class (in %), 2023
Figure 49: Mexico: Purified Proteins Market (in ‘000 US$), 2018-2023
Figure 50: Mexico: Biopharmaceutical Market: Sales Share of Top Players (in %), 2023
Figure 51: Mexico: Biopharmaceutical Market Forecast (in Million US$), 2024-2032
Figure 52: Mexico: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 53: Brazil: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 54: Brazil: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 55: Brazil: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 56: Brazil: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 57: Brazil: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 58: Brazil: Monoclonal Antibodies Market: Sales Share by Class (in %), 2023
Figure 59: Brazil: Purified Proteins Market (in Million US$), 2018-2023
Figure 60: Brazil: Biopharmaceutical Market: Sales Share of Top Players (in %), 2023
Figure 61: Brazil: Biopharmaceutical Market Forecast (in Million US$), 2024-2032
Figure 62: Brazil: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 63: Argentina: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 64: Argentina: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 65: Argentina: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 66: Argentina: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 67: Argentina: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 68: Argentina: Monoclonal Antibodies Market: Sales Share by Class (in %), 2023
Figure 69: Argentina: Purified Proteins Market (in Million US$), 2018-2023
Figure 70: Argentina: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 71: Argentina: Biopharmaceutical Market Forecast (in Million US$), 2024-2032
Figure 72: Argentina: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 73: Germany: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 74: Germany: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 75: Germany: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 76: Germany: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 77: Germany: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 78: Germany: Monoclonal Antibodies Market: Sales Share by Class (in %), 2023
Figure 79: Germany: Purified Proteins Market (in Million US$), 2018-2023
Figure 80: Germany: Purified Proteins Market: Sales Share by Class (in %), 2023
Figure 81: Germany: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 82: Germany: Biopharmaceutical Market Forecast (in Million US$), 2024-2032
Figure 83: Germany: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 84: France: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 85: France: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 86: France: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 87: France: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 88: France: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 89: France: Monoclonal Antibodies Market: Sales Share by Class (in %), 2023
Figure 90: France: Purified Proteins Market (in Million US$), 2018-2023
Figure 91: France: Biopharmaceutical Market: Sales Share of Top Players (in %), 2023
Figure 92: France: Biopharmaceutical Market Forecast (in Million US$), 2024-2032
Figure 93: France: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 94: Italy: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 95: Italy: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 96: Italy: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 97: Italy: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 98: Italy: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 99: Italy: Monoclonal Antibodies Market: Sales Share by Class (in %), 2023
Figure 100: Italy: Purified Proteins Market (in Million US$), 2018-2023
Figure 101: Italy: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 102: Italy: Biopharmaceutical Market Forecast (in Million US$), 2024-2032
Figure 103: Italy: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 104: Spain: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 105: Spain: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 106: Spain: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 107: Spain: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 108: Spain: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 109: Spain: Monoclonal Antibodies Market: Sales Share by Class (in %), 2023
Figure 110: Spain: Purified Proteins Market (in Million US$), 2018-2023
Figure 111: Spain: Purified Proteins Market: Sales Share by Class (in %), 2023
Figure 112: Spain: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 113: Spain: Biopharmaceutical Market Forecast (in Million US$), 2024-2032
Figure 114: Spain: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 115: UK: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 116: UK: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 117: UK: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 118: UK: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 119: UK: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 120: UK: Monoclonal Antibodies Market: Sales Share by Class (in %), 2023
Figure 121: UK: Purified Proteins Market (in Million US$), 2018-2023
Figure 122: UK: Purified Proteins Market: Sales Share by Class (in %), 2023
Figure 123: UK: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 124: UK: Biopharmaceutical Market Forecast (in Million US$), 2024-2032
Figure 125: UK: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 126: Russia: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 127: Russia: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 128: Russia: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 129: Russia: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 130: Russia: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 131: Russia: Monoclonal Antibodies Market: Sales Share by Class (in %), 2023
Figure 132: Russia: Purified Proteins Market: (in Million US$), 2018-2023
Figure 133: Russia: Purified Proteins Market: Sales Share by Class (in %), 2023
Figure 134: Russia: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 135: Russia: Biopharmaceutical Market Forecast (in Million US$), 2024-2032
Figure 136: Russia: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 137: Turkey: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 138: Turkey: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 139: Turkey: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 140: Turkey: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 141: Turkey: Monoclonal Antibodies Market: Sales Share by Class (in %), 2023
Figure 142: Turkey: Purified Proteins Market (in Million US$), 2018-2023
Figure 143: Turkey: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 144: Turkey: Biopharmaceutical Market Forecast (in Million US$), 2024-2032
Figure 145: Turkey: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 146: Japan: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 147: Japan: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 148: Japan: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 149: Japan: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 150: Japan: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 151: Japan: Monoclonal Antibodies Market: Sales Share by Class (in %), 2023
Figure 152: Japan: Purified Proteins Market (in Million US$), 2018-2023
Figure 153: Japan: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 154: Japan: Biopharmaceutical Market Forecast: Value trend (in Million US$), 2024-2032
Figure 155: Japan: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 156: China: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 157: China: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 158: China: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 159: China: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 160: China: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 161: China: Monoclonal Antibodies Market: Sales Share by Class (in %), 2023
Figure 162: China: Purified Proteins Market: (in Million US$), 2018-2023
Figure 163: China: Purified Proteins Market: Sales Share by Class (in %), 2023
Figure 164: China: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 165: China: Biopharmaceutical Market Forecast (in Million US$), 2024-2032
Figure 166: China: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 167: Australia: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 168: Australia: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 169: Australia: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 170: Australia: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 171: Australia: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 172: Australia: Monoclonal Antibodies Market: Sales Share by Class (in %), 2023
Figure 173: Australia: Purified Proteins Market (in Million US$), 2018-2023
Figure 174: Australia: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 175: Australia: Biopharmaceutical Market Forecast (in Million US$), 2024-2032
Figure 176: Australia: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 177: South Korea: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 178: South Korea: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 179: South Korea: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 180: South Korea: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 181: South Korea: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 182: South Korea: Monoclonal Antibodies Market: Sales Share by Class, (in %), 2023
Figure 183: South Korea: Purified Proteins Market (in Million US$), 2018-2023
Figure 184: South Korea: Purified Proteins Market: Sales Share by Class (in %), 2023
Figure 185: South Korea: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 186: South Korea: Biopharmaceutical Market Forecast (in Million US$), 2024-2032
Figure 187: South Korea: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 188: India: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 189: India: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 190: India: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 191: India: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 192: India: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 193: India: Purified Proteins Market (in Million US$), 2018-2023
Figure 194: India: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 195: India: Biopharmaceutical Market Forecast (in Million US$), 2024-2032
Figure 196: India: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 197: Indonesia: Biopharmaceutical Market (in Million US$), 2018-2023
Figure 198: Indonesia: Biopharmaceutical Market: Sales by Class (in Million US$), 2018-2023
Figure 199: Indonesia: Recombinant Proteins Market (in Million US$), 2018-2023
Figure 200: Indonesia: Recombinant Proteins Market: Sales Share by Class (in %), 2023
Figure 201: Indonesia: Monoclonal Antibodies Market (in Million US$), 2018-2023
Figure 202: Indonesia: Monoclonal Antibodies Market: Sales Share by Class (in %), 2023
Figure 203: Indonesia: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 204: Indonesia: Biopharmaceutical Market Forecast (in Million US$), 2024-2032
Figure 205: Indonesia: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2032
Figure 206: Global: Share of Biopharmaceuticals & Small Molecule Drugs Among the Top Ten Selling Drugs (in %), 2001 & 2022
Figure 207: Using a Different Manufacturing Process Makes it Extremely Difficult for Biosimilars to be Equivalent to Originator Products
Figure 208: Marked Differences Between Biosimilar and Branded Biopharmaceuticals When a Different Production Process was Used
Figure 209: Transition Probabilities of Biopharmaceuticals & Small Molecule Drugs in Clinical Phases, (in %)
Figure 210: Comparison of the Average Annual Cost of Therapy Using Biopharmaceuticals and Small Molecule Drugs (in US$)
Figure 211: Emerging Biopharmaceutical Market Forecast (in Million US$), 2023 & 2032
Figure 212: Developed Biopharmaceutical Market Forecast (in Million US$), 2023 & 2032
Figure 213: Breakup of Biopharmaceuticals and Small Molecule Drugs Receiving FDA Approval (in Numbers), 2002-2022
Figure 214: A Comparison of the Costs Incurred While Developing Biopharmaceuticals and Small Molecule Drugs (in Million US$)
Figure 215: Comparison of the Research & Development Times for Biopharmaceuticals & Small Molecule Drugs (in Months)
List of Tables
Table 1: Global: Biopharmaceutical Market: Definition & Segmentation
Table 2: Global: Biopharmaceutical Market: SWOT Analysis
Table 3: Global: Biopharmaceutical Market Forecast: Sales by Region (in Million US$), 2023 & 2032
Table 4: Differences Between Small Molecule Drugs & Biopharmaceuticals
Table 5: Complexity of Manufacturing Process Involved with Biopharmaceuticals & Small Molecule Drugs
Table 6: Global: Biopharmaceutical Market: Sales by Country (in Million US$), 2018-2023
Table 7: Global: Biopharmaceutical Market Forecast: Sales by Country (in Million US$), 2024-2032
Table 8: Global: Biopharmaceutical Market: Sales by Indication (in Billion US$), 2023
Table 9: Mode of Administration of Popular Biotech Drugs
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More